Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001088875-25-000017
Filing Date
2025-02-12
Accepted
2025-02-12 09:11:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5366
  Complete submission text file 0001088875-25-000017.txt   7012
Mailing Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EH13AN
Business Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EH13AN 00441312752000
BAILLIE GIFFORD & CO (Filed by) CIK: 0001088875 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: SCHEDULE 13G/A

Mailing Address 60 RUE DE WATTIGNIES PARIS I0 75012
Business Address 60 RUE DE WATTIGNIES PARIS I0 75012 33140260470
Nanobiotix S.A. (Subject) CIK: 0001760854 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91935 | Film No.: 25612308
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)